APA (7th ed.) Citation

Matranga, G., Carollo, A., Alaimo, M., Cutaia, S., Rizzo, S., & Provenzani, A. Safety profiles of the new target therapies—pemigatinib, futibatinib, and ivosidenib—for the treatment of cholangiocarcinoma: A systematic review. SAGE Publishing.

Chicago Style (17th ed.) Citation

Matranga, Giulia, Anna Carollo, Miriam Alaimo, Sofia Cutaia, Sergio Rizzo, and Alessio Provenzani. Safety Profiles of the New Target Therapies—pemigatinib, Futibatinib, and Ivosidenib—for the Treatment of Cholangiocarcinoma: A Systematic Review. SAGE Publishing.

MLA (9th ed.) Citation

Matranga, Giulia, et al. Safety Profiles of the New Target Therapies—pemigatinib, Futibatinib, and Ivosidenib—for the Treatment of Cholangiocarcinoma: A Systematic Review. SAGE Publishing.